Rigorous genetic diagnosis review in natural history studies.
WHY IT MATTERS
If you or a family member has suspected leukodystrophy but haven't received a confirmed diagnosis, this research could lead to faster, more accurate testing that helps doctors start appropriate treatment sooner.
Researchers are working to improve how doctors diagnose leukodystrophies, a group of rare brain diseases that damage the white matter (the brain's communication pathways). The challenge is that many of these diseases look similar and genetic tests don't always give clear answers. A research project called the Myelin Disorders Biorepository is developing better ways to diagnose these conditions and understand how they progress over time.
Rigorous genetic diagnosis review in natural history studies. Abstract: Leukodystrophies are a clinically and genetically heterogeneous group of diseases characterized by white matter abnormalities on brain magnetic resonance imaging. Clinical, biochemical, molecular, and/or neuroimaging findings collectively support the diagnosis confirmation. The heterogeneous and overlapping clinical presentations of different leukodystrophies and non-diagnostic molecular testing pose a significant challenge to establishing a definitive diagnosis in these rare diseases. The Myelin Disorders Biorepository Project is an observational research program that aims to establish new tests to diagnose leukodystrophies and describe the natural history of these disorders. Ensuring an accurate diagnosis is critical to the goals of this project, and this paper aims to describe the rigor Authors: Pizzino et al. Journal: Orphanet journal of rare diseases MeSH: Humans, Magnetic Resonance Imaging, Genetic Testing, Rare Diseases